Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma
2024 · Biomarker Research · 72 citations
https://doi.org/10.1186/s40364-023-00535-z
Z
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
942
Citations
15
h-index
22
i10-index
Ziyu Xun is an academic researcher from Chinese Academy of Medical Sciences & Peking Union Medical College. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Hepatocellular Carcinoma Treatment and Prognosis & Cancer Immunotherapy and Biomarkers. The author has an h-index of 15, co-authored 46 publications.
Papers by this author
worksGenomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma
2024 · BMC Medicine · 37 citations
https://doi.org/10.1186/s12916-024-03257-7
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
2024 · Biomarker Research · 28 citations
https://doi.org/10.1186/s40364-024-00607-8
Single-cell RNA sequencing in cancer research: discovering novel biomarkers and therapeutic targets for immune checkpoint blockade
2023 · Cancer Cell International · 19 citations
https://doi.org/10.1186/s12935-023-03158-4
Management and treatment of severe immune-related hepatotoxicity based on clinical and pathological characteristics
2024 · Hepatology International · 9 citations
https://doi.org/10.1007/s12072-024-10688-0
Peripheral blood PD-1+ T lymphocytes as biomarkers in liquid biopsies for solid tumors: Clinical significance and prognostic applications
2025 · International Immunopharmacology · 8 citations
https://doi.org/10.1016/j.intimp.2025.114052
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat